Tuberculosis (TB) is a chronic infectious disease caused by Mycobacterium tuberculosis. Poverty, malnutrition and crowded living conditions have been recognized for decades to increase the risk of developing TB. In addition, lack of knowledge about TB could affect the health-seeking behavior of patients and sustain the transmission of the disease within the community. A community based cross-sectional study was conducted in 4 randomly selected rural kebeles around Shashemene area to assess the community's knowledge about TB between March and May, 2011. A total of 422 voluntary residents were included. The study participants were interviewed about the cause, symptoms, mode of transmissions, treatment and preventive methods of tuberculosis. Despite the fact that higher proportion of the study participants 243 (58.8%, 95% CI, 51.6 to 63.1%) had good level of knowledge about TB almost all (90.2%) of them did not know the causative agent of TB. Farmer participants (OR = 2.18; 95% CI: 1.07 to 4.42) had low level of overall knowledge on TB. Almost all (98.98%) of the participants mentioned that TB is a treatable disease. The majority (96.44%) of the participants knew that TB can be transmitted from a patient to another person. The results of this study revealed that the community members in the present study area had little knowledge of the causative agent of TB and hence implementation of appropriate community-based health education is important to raise community's knowledge about TB.
Purpose Multidrug resistant tuberculosis is an emerging problem in many parts of the world. The aim of this study was to determine the drug resistance pattern of Mycobacterium tuberculosis complex in Oromia Region of Ethiopia. Patients and Methods A cross-sectional study was conducted from Jan 2017 to June 2018 on 450 pulmonary tuberculosis patients who visited health facilities in nine administrative zones of Oromia Region. Socio-demographic characteristics and relevant clinical information were obtained using a structured questionnaire. Line Probe Assay for first and second line drugs was used to assess the pattern of drug resistance. SPSS version 20 was used for statistical analysis. Results Median age was 26 years and 240 (53.3%) patients were males. About 24% of them were previously treated for tuberculosis. Thirty-four (7.6%) were HIV co-infected. Line Probe Assay interpretable results were obtained for 387 isolates. Thirty (7.8%) were resistant to rifampicin and isoniazid and thus were multidrug resistant isolates. Among the multidrug resistant samples, three were found to be extensively drug resistant and one was pre-extensively drug resistant. Previous treatment history (AOR 9.94 (95% CI 3.73–26.51), P < 0.001) and nutritional status below normal (AOR 3.15 (95% CI 1.13–8.81), P < 0.029) were found to be associated with multidrug resistance. The chi-square tests have shown that there was a significant difference between the BCG vaccinated and the non-vaccinated in developing multidrug resistant tuberculosis at P = 0.027. Conclusion The proportion of multidrug resistance is above the WHO estimate for the country, Ethiopia, and the fact that some zones were at risk of transmission of extensively drug resistant tuberculosis warrant great attention of the control program holders even though it has to be verified through the conventional method.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.